Neurophet to Participate in RSNA 2024: Unveiling Multiple Sclerosis Analysis Technology with Neurophet AQUA
Demonstrates MS Analysis Technology,Recently Secured FDA 510(k) Clearance Introduces \'Neurophet AQUA AD,\' a Total Solution for Alzheimer\'s Disease Treatment Prescription,at the AI Theater